ABSTRACT
A hipertensão arterial sistêmica (HAS) pode estar associada ou mesmo fazer parte de um conjunto de fatores de risco metabolicamente interligados, os quais determinarão a presença futura de complicações cardiovasculares. É importante o conhecimento dos mecanismos envolvidos com o aumento da pressão arterial e o os níveis elevados das lipoproteínas ricas em colesterol. Evidências sugerem que a hipercolesterolemia colabora para a progressão da hipertensão arterial por meio da ativação do sistema renina-angiotensina, da redução da disponibilidade de óxido nítrico e da disfunção endotelial. Outros mecanismos descritos são sensibilidade ao sal, secreção de substâncias vasoativas e enriquecimento das membranas celulares com excesso de colesterol. Esses mecanismos agem sinergicamente na exacerbação do processo aterosclerótico. A otimização terapêutica no controle pressórico e na redução dos níveis de colesterol deve ser alcançada, principalmente nos pacientes de alto risco para eventos cardiovasculares.
Subject(s)
Humans , Cardiovascular Diseases , Endothelium/physiopathology , Hypercholesterolemia , Hypertension , Nitric Oxide , Renin-Angiotensin System , Risk FactorsABSTRACT
OBJECTIVE: To determine the accuracy of snoring and apnea analysis by SNAP (SNAP Laboratories; Glenview, IL), a technology that uses snoring recorded by a home microphone system and nasal airflow, to diagnose obstructive sleep apnea (OSA) as well as determine its severity. METHODS: For all patients who had undergone a prior SNAP study and were referred to the Sleep Disorders Center of Lifespan Hospitals for polysomnography testing from January 2000 through December 2001, we compared the results of the SNAP study to standard polysomnography (polysomnography). The severity of each apnea-hypopnea index (AHI) [mild, moderate, or severe, as defined by the AHI Severity Task Force of the American Academy of Sleep Medicine] recorded by SNAP was compared to that of the polysomnography result. All polysomnography tests were scored independently and without the prior knowledge of any SNAP results. RESULTS: For the 31 patients on whom data were available, the mean age, body mass index, and Epworth sleepiness scale scores were 50.3 years (range, 29 to 77 years), 31.6 kg/m(2) (range, 24 to 44 kg/m(2)), and 11.3 (range, 1 to 20), respectively. The mean follow-up time between the two studies was 5 months. The severity criteria indicated by the SNAP study accurately assessed the true severity confirmed by polysomnography in only 11 of 31 patients (35.5%). When the AHI severity score from the SNAP study was compared to polysomnography using a kappa statistic measure of agreement, there was overall agreement with a kappa value of 0.23 (p = 0.008), but the agreement was only fair. SNAP study severity scores were overestimated in 13 of 31 patients (41.9%) compared to the polysomnography results. In the majority of these subjects (8 of the 13 "overestimated" patients or 8 of 31 total patients [25.8%]), the SNAP study diagnosed OSA when the patient had a normal polysomnography finding. CONCLUSION: Although there may be some night-to-night variability in polysomnography testing, these results suggest that SNAP studies do not appear to accurately assess the severity of OSA.
Subject(s)
Polysomnography , Sleep Apnea, Obstructive/diagnosis , Sound Spectrography , Adult , Aged , Female , Humans , Male , Middle Aged , Pulmonary Ventilation , Snoring/diagnosisABSTRACT
Durante los últimos 10 años (1983-1992) se sometieron al Comité de Investigación de la Clínica Infantil "Dr. Robert Reid Cabral" 356 investigaciones, unos 35 trabajos por año, donde se involucraron 40 servicios. En su mayoría fueron investigaciones clínicas, transversales, propias de los servicios, utilizadas para tesis de grado y postgrado de las universidades. De éstas un 36 por ciento fueron trabajos colaborativos nacionales principalmente con el laboratorio Nacional Dr. Defilló o internacionales con el Hospital de Niños Washington, D. C. USA
